*Compared to a human.
[0]presumptively
[0] accounting for false positives, screening costs for true negatives, etc. etc.
Increase in false negative rate significantly reduces survival rate and increases cost of treatment. We have huge multiplication factor here so decreasing false negative rate is the net positive option at relatively low rates.
Based on my very superficial medical understanding, screening is already the cheap part. But every false-positive would lead to a doctor follow up at best and a biopsy at worst. Not to mention the significant psychological effects this has on a patient.
So I would counter that the potential increase of false-positive MRI scans could be enough to tip off the scale to make screening less useful